INTRODUCTION
The kidney plays a key role in the secretion and subsequent elimination of drugs, toxins, and other xenobiotics from the body (Koepsell et al., 2003; Koepsell, 2004; Jonker and Schinkel, 2004; Wright and Dantzler, 2004) . Many of these compounds are organic cations in that they carry a net positive charge at physiological pH, including compounds from a broad array of chemical and clinical classes (e.g., antiarrhythmics, β-adrenoreceptor blocking agents, antihistamines, antivirals, and skeletal muscle relaxing agents). Organic cations (and bases; collectively, 'OCs') are actively secreted by the proximal tubule by means of a two-step process (Wright and Dantzler, 2004) . The first step involves transport of OC from the blood, across the basolateral membrane, into the proximal tubule cell via electrogenic, facilitated diffusion. The second step appears to be dominated by an organic cation/proton (OC/H + ) exchanger located in the apical membrane that transports the OC out of proximal cells into the tubular filtrate. Several of the organic cation transporters (OCTs) thought to play a role in the transport of these compounds across the basolateral membrane have been cloned in recent years, including OCT1, OCT2, and OCT3 (Wright and Dantzler, 2004; Koepsell and Endou, 2004; Koepsell et al., 2003) . OCT1 and OCT2 appear to play the predominant role in secretion of the so-called 'Type I' OCs (i.e., generally monovalent, hydrophilic, MW < 400; (Meijer et al., 1990) ) in rodent and rabbit proximal tubules (Karbach et al., 2000; van Montfoort et al., 2001; Kaewmokul et al., 2003; Zhang et al., 2003) . Indeed, active secretion of the prototypic Type I substrate, tetraethylammonium (TEA) is eliminated in the OCT1/2 null mouse (Jonker et al., 2003) . In the human, however, comparatively low expression of the mRNAs for OCT1 and OCT3, relative to OCT2 (Motohashi et al., 2002) , supports the conclusion that OCT2 is probably the principal basolateral route for OC uptake into human proximal tubule cells. An understanding of the This article has not been copyedited and formatted. The final version may differ from this version. physical and structural characteristics that influence the binding of substrates to OCT2 would, therefore, assist in the development of models of substrate interaction with OCT2. Such models offer the promise of predicting clinically deleterious drug interactions and aiding in the design of novel pharmacological agents alongside the widely described in vitro and in vivo models used for generating much of the data on these transporters (Jonker and Schinkel, 2004) .
Previous studies have shown hydrophobicity and basicity to be important determinants of substrate specificity for OCTs in the apical and basolateral membranes of the rat proximal tubule (Ullrich, 1999; Ullrich et al., 1991) . More recent work showed that placement of planar hydrophobic mass, relative to a positively charged nitronium nucleus, is important for substrate binding to hOCT1 (Bednarczyk et al., 2003) and to the OC/H + exchanger in rabbit renal brush border membrane vesicles (Wright and Wunz, 1999) . In contrast, relatively little is known of the structural requirements for OCT2 substrate binding, other than the critical role of the degree of ionization identified by the increased IC 50 values of weak bases when external pH is shifted from 7 to 8 (thereby decreasing protonation; (Barendt and Wright, 2002) ). In the present study, substrate/transporter interactions were investigated on a much larger scale in an attempt to identify distinct molecular characteristics that play a role in selectivity of OCT2. To accomplish this, a set of structurally diverse compounds was chosen for inhibition studies with the human and rabbit orthologs of OCT2 that were stably transfected in CHO cells. This effort to develop a strategy for predicting molecular criteria that influence binding to OCT2 involved use of two different computational methods to generate 2D-and 3D-quantitative structure activity relationship (QSAR) models. Whereas both approaches proved more effective for predicting substrate-transporter interactions than simple substrate hydrophobicity, the 3D-QSAR proved to have greater predictive power, suggesting that steric factors play a more important role in the binding process than previously acknowledged.
Materials and Methods

Chemicals.
[ Chemistry at the University of Arizona (Tucson, AZ). NBD-TMA was synthesized as described previously (Bednarczyk et al., 2000) . The set of N-1 substituted pyridiniums and quinoliniums and ethyl acridinium were synthesized as described previously (Wright et al., 1995 OC, [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium; NBD-TMA (Bednarczyk et al., 2000) ) and selected with 1 mg/ml geneticin (Gibco, Rockville, MD Modeling with Cerius 2 . The computational molecular modeling studies were carried out as described in more detail previously (Bednarczyk et al., 2003) (Clement and Mehl, 2000) pharmacophore for the selective inhibitors of rbOCT2 (cimetidine, guanidine, NBD-TMA, N1-hydroxyethylpyridinium) and hOCT2 (carbachol, tyramine, choline, nicotine, metformin and serotonin). TPrA, clonidine and TBA were comparatively selective inhibitors for rbOCT2 but were severely limited in the number of molecular features that could be used for successful pharmacophore generation and were, therefore, excluded from our analysis.
Up to 255 conformers were generated for each molecule with the fast conformer generation method allowing a maximum energy of 20 kcal/mol. The principal molecule for hOCT2 was carbachol, to which the other molecules were aligned, whereas for rbOCT2 the molecules were aligned to cimetidine. Substrate molecules were then aligned using hydrophobic, hydrogen bond acceptor, hydrogen bond donor and positive charge and positive ionizable features in the HipHop algorithm within Catalyst™.
Results
Kinetics of TEA transport mediated by the human and rabbit orthologs of OCT2. 
where J is the rate of [ substrates for human and rabbit OCT2. With the exception of several anionic inhibitors, the kinetics of inhibition were well described by the relationship (Groves et al., 1994) :
where J app is defined as (K i /K t )J max , [I] is the concentration of the test agent, and K app is an apparent inhibitory constant (K i ) for the test agent that is defined as
This article has not been copyedited and formatted. The final version may differ from this version. compounds (e.g., cimetidine, tyramine, NBD-TMA; (Bednarczyk et al., 2000; Kaewmokul et al., 2003) and unpublished observations), and reasonably assumed to be the case for others (owing to marked structural similarities with molecules known to be OCT2 substrates), we have not rigorously proven this to be the case for all compounds used in this study. Consequently, we will henceforth refer to the kinetic constants calculated through application of equation 2 as 'IC 50 '
values.
The test agents used here were selected to represent a broad range of the parameters suspected of influencing binding to the transport site of OCT2, including hydrophobicity (e.g., ClogP and ALogP98), molecular weight, basicity, and 3D configuration. In addition, we considered it important to have compounds for which OCT2 displayed a broad range of apparent affinities in order to generate QSAR models. Figure 3 shows the effect of increasing the test agent concentration on the inhibition of TEA transport mediated by either hOCT2 (Fig. 3A) or rbOCT2 ( Fig. 3B ) for four representative compounds (ethylacridinium, clonidine, tyramine, and guanidine) with IC 50 values that spanned 5 orders of magnitude. Table 1 lists the IC 50 values for the compounds included in the training and test sets examined in this study. Interestingly, these orthologous transporters displayed both remarkable similarities in their apparent affinities for selected compounds, and marked differences. For example, whereas human and rabbit OCT2
had virtually identical IC 50 values for ephedrine (Fig. 4A ), hOCT2 had a 10-fold higher apparent affinity for carbachol (than rbOCT2; Fig. 4B ), while rbOCT2 had a 20-fold higher apparent affinity for cimetidine (than hOCT2; Fig. 4C ). Figure 5 lower than those measured for the human ortholog. Nevertheless, as suggested by the data presented in Figure 4 , there were a number of exceptions to this general rule. Figure 6 shows the ratio of IC 50 values measured for hOCT2-vs. rbOCT2-mediated transport. Whereas the rabbit OCT2 ortholog displayed a significantly greater affinity (than the human) for 9 of 28 compounds tested, eight of 28 compounds showed the opposite, i.e., hOCT2 displayed a greater affinity for them than did rbOCT2.
As previously mentioned, a positive correlation between hydrophobicity and affinity has been reported for the interaction of substrates and inhibitors of renal OC transporters (e.g., (Ullrich et al., 1991) ). Figure 7 shows the relationship between IC 50 and ALogP98 of the diverse group of inhibitors of hOCT2 employed in the present study. Although there was a significant correlation between these parameters, it was comparatively modest (r 2 = 0.38) and numerous 'outliers' were evident. It is also relevant to note that a plot of IC 50 versus another commonly used calculated hydrophobicity indicator, ClogP, suggested that there was no significant correlation between these parameters (data not shown). This somewhat unexpected observation reflects the fact that the commonly used algorithms for calculation of octanol:water partition coefficients frequently show rather modest agreement with one another, as shown by the comparatively weak correlation (r 2 = 0.27) between AlogP98 and ClogP values for the compounds used in the present study (data not shown). We raise this issue because it underscores the desirability of developing a more precise means to predict the relationship This article has not been copyedited and formatted. The final version may differ from this version. between substrate structure and binding to OCT2 rather than using a predicted measure of hydrophobicity alone.
Generation of QSAR Models for hOCT2 -2D-QSAR (Cerius 2 ). The comparatively
weak correlation between substrate/inhibitor hydrophobicity and the measured interaction with hOCT2 led us to consider a more rigorous method for developing a predictive model of substrate-transporter binding. We have previously used Cerius 2 to develop a descriptor-based QSAR model of substrate binding to hOCT1 (Bednarczyk et al., 2003) , an approach that proved to be superior to one based on the use of Catalyst to develop a 3D pharmacophore of binding to the transporter. Consequently, a descriptor-based 2D-QSAR model for hOCT2 was built using a small selection of the molecular descriptors generated by Cerius was, however, unable to converge on a model describing binding of the training set molecules to rbOCT2 using these same descriptors.
The model outlined in equation 4 was used to predict for hOCT2 the IC 50 values for a test set of six diverse compounds selected to reflect the structural diversity associated with the training set. Although the predicted IC 50 of one of the six test compounds (ibuprofen) was poorly predicted (the open circles in Fig. 8A ), predicted-versus-measured IC 50 s for the remaining five compounds resulted in an r 2 = 0.68.
Inhibition studies with N-1 substituted pyridiniums and quinoliniums with hOCT2.
A set of N-1 substituted pyridiniums containing a phenyl substituent at the 3 or 4 position was investigated to determine if the 3D placement of this hydrophobic mass influenced binding to hOCT2. The N-1 substituent was also varied to increase the compounds hydrophobicity (hydroxyl ethyl< ethyl< benzyl). Table 2 shows the ALogP and IC 50 values generated for each compound. The data show that as the hydrophobic phenyl ring was rotated about the pyridinium, there was no change in affinity for the transporter. However, as hydrophobicity of the N-1 substituent was increased, the affinity for the transporter was also increased. In addition, a set of quinoliniums, also containing the differing N-1 substituents mentioned above, were tested.
Again, affinity was positively correlated with hydrophobicity, and IC 50 values were very similar to those for the corresponding 3 or 4 phenylpyridinium. The correlation between log IC 50 and AlogP and CLogP for these 9 compounds was r 2 = 0.85 and 0.57, respectively, while the Cerius 2 2D-QSAR predicted these same molecules with r 2 = 0.70. In a previous study (Bednarczyk et al., 2003) these two sets of compounds were used to perform inhibition kinetics of TEA in HeLa cells stably transfected with hOCT1; IC 50 values generated in this study are listed in increase in hydrophobicity for all subsets of compounds. However, unlike the situation observed for hOCT2, as the hydrophobic mass was rotated around the pyridinium, IC 50 for interaction with hOCT1 increased, suggesting spatial arrangement of hydrophobic mass effects a compound's interaction with hOCT1 more substantially than with hOCT2.
When all the test set molecules were combined with the training set a total of 45 molecules were available for model building. Using stepwise regression the r 2 decreased to 0.70, Analysis and CoMFA runs and, so, were excluded from both CoMFA models. The QSAR statistics for the best correlation are listed in Table 3 .
3D-QSAR (CoMFA
CoMFA contours at 80% confidence levels were generated for each model and these are shown in Figure 9 . A large blue contour covering the positive center (mainly ammonium)
suggests an important role for positive charge at this position. The small green contour over the phenol ring indicates the necessity of a sterically bulky group at this position. These two features should be expected because of the way our alignment was set up. Quite interestingly, a red contour next to the green contour appeared in both human and rabbit CoMFA models. This suggests a correlation between electronegative charge in the area and higher affinity to OCT2.
Furthermore, this could indicate that a small negative charge or delocalized point charge close to the positive center might play a stabilizing role in the binding of substrates to OCT2. Figure 10 shows the relationship between predicted vs. measured log IC 50 values for the training and test 
Discussion
In light of the increasing pharmacological significance of renal secretion as a defining factor in the bioavailability of a vast array of cationic drugs (Balant and Gex-Fabry, 1990; Chaturvedi et al., 2001) , there is obvious value to the ability to predict the extent to which potential substrates interact with key elements in the renal secretory pathway. Ullrich made a detailed study of the structural specificity of basolateral organic cation transport in rat kidney using the in vivo stopped-flow capillary microperfusion technique (Ullrich et al., 1992 (Arndt et al., 2001; Urakami et al., 2001) . Consequently, the general rules concerning the physicochemical factors that influence substrate binding to OCTs must be viewed as an average response of the interaction with multiple transporters operating in parallel. Nevertheless, the principal factor influencing substrate interaction with OCTs was found to be hydrophobicity, in concurrence with some of the earliest studies on renal OC secretion (Green et al., 1959) . In the present study there was a correlation, albeit weak (r 2 of 0.38), between hydrophobicity and the interaction of our training set with hOCT2. A similar observation was noted in a recent examination of the factors that influence substrate binding to hOCT1 (Bednarczyk et al., 2003) . Although within a group of structurally related compounds binding efficacy can be more closely correlated with hydrophobicity as a single criterion for interaction with OCTs (Dresser et al., 2002) , (Zhang et al., 1999) it is evident, and not surprising, that factors other than the oil:water partition coefficient (or predictors of this property) play key roles in stabilizing substrate binding to OCTs.
The present study is, to the best of our knowledge, the first to apply a combination of in vitro and computational approaches to identify factors other than hydrophobicity that play a role in defining substrate interactions with OCT2. Our effort to develop a strategy for predicting underscore the importance of hydrophobicity as a determinant in influencing substrate binding to hOCT2, as they were dominated by parameters such as AlogP98, CLogP, and Jurs descriptors.
However, a role for steric factors was also suggested in equation 4 by the inclusion of a Shadow parameter (Shadow YZ; area of the molecular shadow in the YZ plane). Interestingly, our previous study on characteristics of binding hOCT1 identified Shadow nu (ratio of largest to smallest dimension) as a principal determinant of substrate interaction for this transporter (Bednarczyk et al., 2003) . In the previous study, we noted that the placement of planar hydrophobic mass about a pyridinium nucleus exerted a systematic effect on binding to hOCT1 (i.e., 4-phenylpyridinium compounds interacted with substantially lower IC 50 values than did, for example, quinolinium compounds), consistent with the conclusion that the hOCT1 binding sites favors binding of 'longer', rather that 'wider,' molecules. In contrast, in the present study, we found no such systematic effect with respect to the binding of 4-phenyl-, 3-phenyl, vs.
quinolinium compounds (Table 2) , and this was reflected in emphasis on binding of a bulk area term (Shadow YZ) rather than a term that emphasized the binding efficacy of long, narrow substrates. The presence of the rotatable bond descriptor suggests that hOCT2 may also prefer flexible substrates, a characteristic not implicated in hOCT1 binding. The degree of substrate ionization indicated as important for hOCT2 substrate binding was not evaluated in these computational studies (Barendt and Wright, 2002) . It should also be noted that both the 2D and 3D analyses employed here implicitly assume that the binding site/region of OCT2 has similar characteristics when exposed to extracellular and cytoplasmic aspects of the membrane and, for at least some substrates (e.g., tetrabutylammonium and corticosterone) this has been shown not to be the case (Volk et al., 2003) . Consequently, the models describe a hypothetical binding site The 3D-QSAR that resulted from application of CoMFA served to emphasize two important issues concerning the influence of molecular size/shape on binding of substrate to
OCTs. First, it underscored the observation, suggested by the 2D-QSAR, that steric factors clearly play a role in the binding process. This is evident in the marked improvement in predictive power of the 3D-QSAR (r 2 of 0.97; Fig 10) compared to the 2D-QSAR (r 2 of 0.8 to 0.9; Fig. 8 ). The second issue evident from the CoMFA, interestingly, was the multispecificity of the binding site evident from the substrate overlays within the binding region (Fig. 9 ).
Although the CoMFA contour plot indicates that binding is enhanced or reduced by, for example, the presence of steric mass in particular positions (i.e., green vs. yellow contours, respectively), it is also evident that the OCT2 binding site (both for human and rabbit) is extremely permissive with respect to the presence and placement of, in particular, hydrophobic moieties that radiate away from positively charged binding center. The capacity to interact effectively with such a structurally diverse set of compounds has important implications for the structural nature of the OCT2 binding site. This clearly represents a challenge for future efforts to model the binding site by identifying structural features that permit comparatively high affinity interactions with molecules as structurally diverse as, for example, MPP (IC 50 of 2.4 µM) and crystal violet (IC 50 of 2.6 µM) ( Table 1) .
Comparison of the selectivity of the human and rabbit orthologs of OCT2 is also instructive. Whereas the two orthologs displayed very similar apparent affinities for many of the test agents, it was also evident that for just as many compounds their selectivities differed substantially (Fig. 5) . Importantly, these differences were not systematic: for some compounds, This article has not been copyedited and formatted. The final version may differ from this version. e.g., carbachol and tyramine, hOCT2 displayed a 5-15-fold higher affinity, whereas for other compounds, e.g., cimetidine and clonidine, it was the rabbit ortholog that displayed a higher (5-10-fold) affinity (Fig. 6) . The primary sequences of human and rabbit OCT2 are 96% similar (83% identical). The differences in selectivity between these two transporters presumably reflect structural differences, quite probably minor ones, the consequences of which include clearly distinct selectivity profiles. While this is not a surprising observation, it serves to emphasize that minor changes in a few amino acid residues can result in very significant changes in selectivity for some substrates, while having no effect on interaction with other substrates. For example, Gorboulev et al. (1999) found that substituting a glutamate residue for the aspartate found at position 475 in rat OCT1 resulted in an 8-fold increase in apparent affinity for TEA, but had no effect on the interaction of the transporter with MPP. Similarly, Leabman et al. (2002) noted that single nucleotide polymorphisms (SNPs) in hOCT2 exerted substrate-specific effects on transport function. For example, the K432Q SNP increased apparent affinity of the transporter for tetrabutylammonium and MPP, while having little or no effect on interaction of the transporter for metformin and quinidine. On the other hand, the A270S SNP decreased apparent affinity for MPP and tetrabutylammonium, while having no significant effect on interaction with metformin and quinidine. The differences in selectivity between the human and rabbit OCT2 also emphasize the care that must be used when extending to humans observations obtained in studies employing non-human orthologs.
Knowing that there are molecules that discriminate between the human and rabbit orthologs of OCT2 provided an opportunity to probe the qualitative differences between molecules with high affinity to the hOCT2 and rOCT2 transporters using a Catalyst HipHop
alignment. An alignment of the selective inhibitors for both transporters indicated subtle but This article has not been copyedited and formatted. The final version may differ from this version. distinctive differences for recognition, which manifested in differences in features and angles recognized for each transporter (Fig. 11A-D) . The assessment of ephedrine, which shows no selectivity for either transporter, indicates that this molecule can adequately map to both pharmacophores (Fig. 11B,C) . This pharmacophore analysis provides valuable information that can be used for testing subsequent homology models for both transporters by comparing the pharmacophores and aligned selective inhibitors docked into the transporters. Even though the features on these pharmacophores are similar, the approach is sensitive enough to identify a difference in the orientation of the hydrogen bonding features (> 37 o ). This could infer variability in the disposition of critical amino acids for interaction with inhibitors within the respective transporters.
In summary, computationally derived QSAR models of the basis of OCT2 selectivity were determined for the human and rabbit orthologs of the renal organic cation transporter, OCT2. A 2D-QSAR emphasized the importance of hydrophobicity as an important determinant in the binding of substrates to OCT2 alongside structural bulk and molecular flexibility. A 3D-QSAR displayed better predictive power and served to emphasize the fact that molecular size and shape plays a significant role in defining the interaction of substrates. The CoMFA models also highlighted the multispecificity of the OCT2 binding site by noting the importance of structural features in selected regions, and the permissiveness of the binding site with respect to steric bulk in other regions. Marked differences in the selectivity of the human and rabbit orthologs of OCT2 also underscored the fact that very modest differences in the amino acid residue composition of the protein can result in substantial changes in affinity of the respective transporters for some substrates while having no effect on the interaction with other substrates.
The general hydrophobic substrate promiscuity of the OCT2 transporter draws immediate inhibitor. Lines were fit to the data using a non-linear regression algorithm (SigmaPlot 3.0).
IC 50 values are listed in Table 1 . is the mean value of at least two separate experiments (described in Materials and Methods).
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Mol#4713 Table 2 IC 50 values for the inhibition of TEA by the phenylpyridiniums and quinoliniums in CHO cells stably transfected with hOCT2 (this study) and HeLa cells stably transfected with hOCT1 (Bednarczyk et al., 2003) . Each IC 50 is the mean value of at least 2 experiments (described in 
